DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» CXCR4 antagonist
CXCR4 antagonist
Single Dose of the CXCR4 Antagonist BL-8040 Induces Rapid
Modulators of CXCR4 and CXCR7/ACKR3 Function
Dynamic Chemotherapy-Induced Upregulation of CXCR4 Expression: a Mechanism of Therapeutic Resistance in Pediatric AML
Promising Therapeutic Targets for Treatment of Rheumatoid Arthritis
Extrinsic Targeting Strategies Against Acute Myeloid Leukemic Stem Cells Noureldien H
Protocol Alert
Updates on the Hematologic Tumor Microenvironment and Its
WO 2017/223229 Al 28 December 2017 (28.12.2017) W !P O PCT
A Phase I Trial of LY2510924, a CXCR4 Peptide Antagonist, in Patients with Advanced
Enhanced Unique Pattern of Hematopoietic Cell Mobilization Induced by the CXCR4 Antagonist 4F-Benzoyl-TN14003
Interplay Between SARS-Cov-2 and the Type I Interferon Response Margarida Sa Ribero, Nolwenn Jouvenet, Marlène Dreux, Sébastien Nisole
A Highly Selective and Potent CXCR4 Antagonist for Hepatocellular Carcinoma Treatment
Current Insights Into Immunology and Novel Therapeutics of Atopic Dermatitis
( 12 ) Patent Application Publication ( 10 ) Pub . No .: US 2021/0023264 A1 CHENG Et Al
Moving Toward Targeted Therapies in Acute Myeloid Leukemia
2018 Medicines in Development for Cancer
CXCR4 Inhibitors: Tumor Vasculature and Therapeutic Challenges
Novel Therapies for Children with Acute Myeloid Leukaemia
Top View
CXCR4 Inhibition in Human Pancreatic and Colorectal Cancers Induces an Integrated
CXCR4 in Waldenström's Macroglobulinema
Chapter 1: Introduction
Role of Inflammatory Mediators, Macrophages, and Neutrophils In
2018 Annual Report
Known Bioactive Library: Selleck Bioactive 10Mm, 3.33Mm, 1.11Mm
Natural Amines Inhibit Activation of Human Plasmacytoid Dendritic Cells Through CXCR4 Engagement
Main Board of the Polish Society of Experimental and Clinical Immunology Bialystok Chapter of the Polish Society of Experimental and Clinical Immunology
Targeting CXCL12/CXCR4 Signaling with Oncolytic Virotherapy Disrupts
Targeting the Tumor Microenvironment in B-Cell Lymphoma
A Novel Small Molecule CXCR4 Antagonist Potently Mobilizes
The Brain-Penetrating CXCR4 Antagonist, PRX177561, Increases
2020 Medicines in Development ꟷ Cancer
Targeting CXCL12/CXCR4 Signaling with Oncolytic Virotherapy Disrupts
REVIEW CXCR4 Antagonists
Genetic Determinants of Response and Survival in Momelotinib-Treated
Mechanisms of G-CSF-Mediated Hematopoietic Stem and Progenitor Mobilization
Transforming Science Into Medicine